BMRA
Biomerica, Inc.NASDAQHealthcare$2.17-0.91%ClosedMarket Cap: $6.6M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
1.42
P/S
1.47
EV/EBITDA
-1.17
DCF Value
$-84.89
FCF Yield
-44.7%
Div Yield
0.0%
Margins & Returns
Gross Margin
5.6%
Operating Margin
-118.1%
Net Margin
-90.3%
ROE
-83.7%
ROA
-66.7%
ROIC
-111.6%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q2 2026 | $1.2M | 4.2% | $-1.4M | $-1.3M | $-0.45 | — |
| Q1 2026 | $1.4M | 30.7% | $-1.1M | $2.0K | $0.00 | — |
| Q4 2025 | $749.0K | -32.6% | $-1.6M | $-1.5M | $-0.16 | — |
| FY 2025 | $5.3M | 9.4% | $-5.1M | $-5.0M | $-2.16 | — |
| Q3 2025 | $1.1M | 1.7% | $-1.2M | $-1.2M | $-0.07 | — |
| Q2 2025 | $1.6M | 26.7% | $-993.0K | $-950.0K | $-0.06 | — |
| Q1 2025 | $1.8M | 16.0% | $-1.4M | $-1.3M | $-0.08 | — |
| Q4 2024 | $1.1M | 1.8% | $-1.5M | $-1.4M | $-0.08 | — |
| FY 2024 | $5.4M | 11.3% | $-6.4M | $-6.0M | $-0.36 | — |
| Q3 2024 | $1.0M | -14.7% | $-2.0M | $-1.9M | $-0.11 | — |
| Q2 2024 | $1.6M | 20.7% | $-1.6M | $-1.5M | $-0.09 | — |
| Q1 2024 | $1.7M | 24.1% | $-1.2M | $-1.1M | $-0.07 | — |